Strengthening Surgical Solutions Across Regions
Osteotec, a prominent manufacturer and distributor of specialized medical devices, is thrilled to announce a significant agreement with Novastep, a renowned leader in innovative surgical technologies. This partnership establishes Osteotec as the exclusive distributor of Novastep's advanced foot and ankle surgical solutions across key regions, including the UK, Ireland, and the Nordic markets.
A Comprehensive Portfolio for Enhanced Clinical Outcomes
This collaboration enhances the expansive portfolio of Osteotec, providing surgeons with access to Novastep’s clinically proven implants. These solutions are designed to effectively address a multitude of conditions, including trauma-related injuries, as well as pathological and congenital deformities. By incorporating Novastep's innovative products, Osteotec reaffirms its commitment to supporting healthcare professionals in delivering superior clinical outcomes.
A Leader in Minimally Invasive Technologies
Based in Rennes, France, Novastep has carved a niche in developing minimally invasive surgical (MIS) technologies. Their products focus on conditions affecting various structures within the foot and ankle, including bones, joints, and soft tissues. The incorporation of Novastep's offerings into Osteotec’s catalog showcases the dedication to improving surgical practices and patient results.
Commitment to Quality and Excellence
Dean Stockwell, the Sales & Marketing Director at Osteotec, emphasized the shared vision of quality between the two companies. "Our aim is to consistently deliver high-caliber solutions to surgeons alongside their patients. Partnering with Novastep enhances our ability to provide the best options available in the market," he stated. This partnership signifies an expansion of Osteotec's service capabilities to new regions while adhering to the high standards that clients expect.
Exciting Opportunities Ahead
The agreement, which becomes effective on January 1, 2025, is anticipated to spur growth in sales and revenue for both companies. Gregory Gledel, General Manager of International Foot & Ankle at Novastep, expressed enthusiasm about the partnership's potential. "This collaboration marks a significant milestone as we aim to broaden our global reach while ensuring that our innovative solutions enhance patient care across the regions we cover. Osteotec's deep market knowledge and unwavering commitment to service excellence are pivotal to achieving these goals," he shared.
Shared Values and Vision
The partnership between Osteotec and Novastep is built on a foundation of shared values, particularly in the realms of advancement, precision, and commitment to patient care. Both organizations recognize the critical importance of leveraging each other's strengths to amplify marketing opportunities and elevate healthcare outcomes.
Pioneering Innovations in Healthcare
"This agreement is a testament to our mutual commitment to growth, innovation, and excellence in the medical field," remarked Dean Stockwell. By collaborating with Novastep, Osteotec reinforces its dedication to advancing surgical technologies and enhancing the overall patient experience.
About Osteotec
Founded in 1993, Osteotec is a leading manufacturer and distributor located in Newbury, UK. With a robust presence in both the NHS and private healthcare sectors over the last 31 years, Osteotec specializes in a range of innovative medical devices. Their product lineup includes the Osteotec Silicone Finger and the Concentric Bone Graft System, among others, reinforcing their reputation for quality.
About Novastep
Novastep is dedicated to designing, developing, and marketing products that address foot and ankle conditions impacting bones, joints, and soft tissues. Their commitment to innovation is supported by their inclusion under Enovis™, a medical technology leader focused on transforming patient outcomes and workflows. Novastep is committed to enhancing surgical education and patient care.
Frequently Asked Questions
What is the main focus of the partnership between Osteotec and Novastep?
The partnership focuses on distributing Novastep's innovative foot and ankle surgical solutions across the UK, Ireland, and Nordic regions.
When does the partnership agreement take effect?
The agent agreement becomes effective on January 1, 2025.
What kind of products will Osteotec distribute?
Osteotec will distribute Novastep’s clinically proven implants designed for various foot and ankle conditions.
How does this partnership benefit healthcare professionals?
This partnership enhances access to innovative solutions that can improve clinical outcomes for patients.
What are Osteotec's core commitments?
Osteotec is committed to quality, innovation, and providing excellent support for healthcare providers and their patients.
